Lydia Visser

5.5k total citations
130 papers, 3.8k citations indexed

About

Lydia Visser is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Lydia Visser has authored 130 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pathology and Forensic Medicine, 55 papers in Immunology and 38 papers in Oncology. Recurrent topics in Lydia Visser's work include Lymphoma Diagnosis and Treatment (66 papers), Immune Cell Function and Interaction (40 papers) and Chronic Lymphocytic Leukemia Research (22 papers). Lydia Visser is often cited by papers focused on Lymphoma Diagnosis and Treatment (66 papers), Immune Cell Function and Interaction (40 papers) and Chronic Lymphocytic Leukemia Research (22 papers). Lydia Visser collaborates with scholars based in Netherlands, Canada and United States. Lydia Visser's co-authors include Sibrand Poppema, Anke van den Berg, Arjan Diepstra, Wim Timens, S Poppema, Hans Vos, Harry Hollema, Ilja M. Nolte, Tjasso Blokzijl and Joost Kluiver and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Lydia Visser

128 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lydia Visser Netherlands 36 1.6k 1.6k 1.3k 1.0k 545 130 3.8k
Horst Dürkop Germany 28 1.7k 1.1× 1.6k 1.0× 1.2k 0.9× 825 0.8× 422 0.8× 58 3.9k
Arjan Diepstra Netherlands 36 1.3k 0.8× 1.7k 1.1× 1.5k 1.1× 968 0.9× 472 0.9× 161 3.6k
Steven C. Ziesmer United States 35 1.5k 1.0× 1.2k 0.8× 1.2k 0.9× 580 0.6× 716 1.3× 65 3.2k
Javier Briones Spain 35 1.7k 1.1× 1.3k 0.9× 1.9k 1.4× 831 0.8× 957 1.8× 161 4.5k
Hans‐Dieter Foss Germany 32 1.1k 0.7× 2.4k 1.6× 1.7k 1.3× 774 0.8× 780 1.4× 69 4.0k
Giovanna Roncador Spain 38 3.1k 1.9× 2.4k 1.6× 2.3k 1.7× 1.1k 1.1× 671 1.2× 102 6.0k
Harald Stein Germany 33 1.1k 0.7× 1.9k 1.2× 1.5k 1.1× 941 0.9× 672 1.2× 53 4.0k
Anne J. Novak United States 41 3.2k 2.0× 2.1k 1.3× 2.4k 1.8× 1.2k 1.2× 1.1k 2.1× 142 5.7k
Claudio Agostinelli Italy 30 992 0.6× 2.0k 1.3× 1.5k 1.1× 624 0.6× 585 1.1× 151 3.3k
Sylvia Hartmann Germany 31 759 0.5× 1.6k 1.0× 1.6k 1.2× 744 0.7× 494 0.9× 148 3.0k

Countries citing papers authored by Lydia Visser

Since Specialization
Citations

This map shows the geographic impact of Lydia Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Visser more than expected).

Fields of papers citing papers by Lydia Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lydia Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Visser. The network helps show where Lydia Visser may publish in the future.

Co-authorship network of co-authors of Lydia Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Visser. A scholar is included among the top collaborators of Lydia Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Visser. Lydia Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bröckelmann, Paul J., Lydia Visser, Conrad‐Amadeus Voltin, et al.. (2024). Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial. Blood. 144(Supplement 1). 3044–3044. 1 indexed citations
2.
Zhao, Xiaojuan, Marjory Koller, Gert Jan Meersma, et al.. (2022). Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett’s Esophagus. Cancers. 14(10). 2462–2462. 4 indexed citations
3.
Höppener, Diederik J., Pieter M. H. Nierop, Kostandinos Sideras, et al.. (2020). Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis. British Journal of Cancer. 123(2). 196–206. 35 indexed citations
4.
Dzikiewicz‐Krawczyk, Agnieszka, Arjan Diepstra, Bea Rutgers, et al.. (2018). Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells. American Journal Of Pathology. 188(5). 1289–1299. 6 indexed citations
5.
Yuan, Ye, Ilja M. Nolte, Jasper Koerts, et al.. (2018). MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma. Cellular Physiology and Biochemistry. 49(1). 144–159. 24 indexed citations
6.
Yuan, Ye, Joost Kluiver, Jasper Koerts, et al.. (2017). miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis. American Journal Of Pathology. 187(6). 1343–1355. 46 indexed citations
7.
Diepstra, Arjan, Debora de Jong, Jasper Koerts, et al.. (2016). MUTATIONS IN CD58 AND MYB IN HODGKIN LYMPHOMA. Haematologica. 101. 4–5. 1 indexed citations
8.
Eijndhoven, Monique A.J. van, Josée M. Zijlstra, Esther E.E. Drees, et al.. (2016). Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight. 1(19). e89631–e89631. 129 indexed citations
9.
Diepstra, Arjan, et al.. (2015). CD57+ T-cells are a subpopulation of T-follicular helper cells in nodular lymphocyte predominant Hodgkin lymphoma. Experimental Hematology and Oncology. 4(1). 27–27. 8 indexed citations
10.
Kushekhar, Kushi, Anke van den Berg, Ilja M. Nolte, et al.. (2014). Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2737–2747. 34 indexed citations
11.
Niens, Marijke, Lydia Visser, Ilja M. Nolte, et al.. (2008). Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. British Journal of Haematology. 140(5). 527–536. 89 indexed citations
12.
Lazarovits, Andrew I., Lydia Visser, Toni Zhong, et al.. (1999). Mechanisms of induction of renal allograft tolerance in CD45RB-treated mice. Kidney International. 55(4). 1303–1310. 16 indexed citations
13.
Diepstra, Arjan, et al.. (1997). The absence of effective T-cell activation in Hodgkin's disease may be the result of TGF beta production by Reed-Sternberg cells.. Blood. 90(10). 3938–3938. 1 indexed citations
14.
Poppema, Sibrand & Lydia Visser. (1996). Some CD26 reagents directly activate T cells.. Data Archiving and Networked Services (DANS). 1 indexed citations
15.
Poppema, Sibrand, et al.. (1996). CD45(R) reagents can modulate the T cell response in vitro and in vivo.. Blood. 88(10). 633–633. 1 indexed citations
16.
Poppema, Sibrand & Lydia Visser. (1996). Differential effects of CD45 reagents on T cell activation.. Data Archiving and Networked Services (DANS). 48. 2 indexed citations
17.
Poppema, S & Lydia Visser. (1995). Immunophenotype and functional characteristics of T cells in Hodgkin's disease. Blood. 86(10). 1345–1345. 1 indexed citations
18.
Cutsem, Eric Van, Karel Geboes, Lydia Visser, et al.. (1991). Squamous papillomatosis of the oesophagus with malignant degeneration and demonstration of the human papilloma virus. European Journal of Gastroenterology & Hepatology. 3(7). 561–566. 11 indexed citations
19.
Visser, Lydia & Sibrand Poppema. (1990). Induction of B‐cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B‐cells. British Journal of Haematology. 75(3). 359–365. 15 indexed citations
20.
Poppema, Sibrand, et al.. (1985). Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Cancer. 55(4). 683–690. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Horst Dürkop Breakdown of academic impact, for papers by Arjan Diepstra Breakdown of academic impact, for papers by Steven C. Ziesmer Breakdown of academic impact, for papers by Javier Briones Breakdown of academic impact, for papers by Hans‐Dieter Foss Breakdown of academic impact, for papers by Giovanna Roncador Breakdown of academic impact, for papers by Harald Stein Breakdown of academic impact, for papers by Anne J. Novak Breakdown of academic impact, for papers by Claudio Agostinelli Breakdown of academic impact, for papers by Sylvia Hartmann
Rankless by CCL
2026